Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GBGT1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | CHCHD10 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | CHTOP | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | MEX3B | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | LMO2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CHCHD4 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | UBR5 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | PSMB4 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | HMX3 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |